Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of the SurgWerksTM-CLI Kit and VXPTM System for the Rapid Intra-operative Aspiration, Preparation and Intramuscular Injection of Concentrated Autologous Bone Marrow Cells Into the Ischemic Index Limb of Rutherford Category 5 Non-Reconstructable Critical Limb Ischemia Patients

NCT02538978 is registered in ClinicalTrials.gov with Cesca Therapeutics, Inc. as lead sponsor.

NCT NCT02538978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02538978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of the SurgWerksTM-CLI Kit and VXPTM System for the Rapid Intra-operative Aspiration, Preparation and Intramuscular Injection of Concentrated Autologous Bone Marrow Cells Into the Ischemic Index Limb of Rutherford Category 5 Non-Reconstructable Critical Limb Ischemia Patients
Lead sponsor
Cesca Therapeutics, Inc.
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2017
Completion date
March 31, 2019
Enrollment
224 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia (cli)